Bolt Biotherapeutics, Inc. (BOLT) Financials

BOLT Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 175.4 million 47.1 million
2023-06-30 190.7 million 48.6 million
2023-03-31 206.2 million 48.5 million
2022-12-31 227.8 million 56.3 million

BOLT Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -16.9 million 2.3 million
2023-06-30 -15.1 million 2.4 million
2023-03-31 -23.4 million 2.5 million
2022-12-31 -18.1 million 2.1 million

BOLT Net Income

No data available :(

BOLT Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 119.7 million - 20.9 million
2023-06-30 125.9 million - 21.5 million
2023-03-31 126.4 million - 22.1 million
2022-12-31 168.9 million - 22.6 million

BOLT Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 37.9 million
2023-06-30 37.8 million
2023-03-31 37.7 million
2022-12-31 37.6 million

BOLT Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 165000 15.0 million 5.8 million -
2023-06-30 32000 15.6 million 5.6 million -
2023-03-31 3000 14.6 million 5.6 million -
2022-12-31 184000 16.8 million 5.6 million -

BOLT Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 2.5 million 462000
2023-06-30 1.4 million 1.2 million
2023-03-31 1.8 million 1.2 million
2022-12-31 1.4 million 1.2 million

BOLT

Price: $1.10

52 week price:
0.84
2.03

Payout Ratio Range:
7.70%
183.33%

Earnings Per Share: -1.83 USD

P/E Ratio: -0.58

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 121100

Market Capitalization: 50.3 million

Average Dividend Frequency: 4

Links: